The invention relates to substituted xanthines of general formula (I) wherein R<1> to R<3> have the designations cited in patent claims, and to the tautomers, stereoisomers, mixtures, prodrugs and salts thereof, which have precious pharmacological properties, especially an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).